Delivery Order SPE2DR25D2005-SPE2DR26FF6G9
Award Date 4/1/26
Potential Completion Date 4/22/26
Potential Value $8.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 17, 2026. Pricing is firm fixed price. The order was issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2026, which supports global pharmaceutical supply to military healthcare...
- The Defense Logistics Agency issued a $8,561.41 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for IBRANCE 75 MG tablets (7-count units), with an ultimate completion date of April 22, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing under a no-set-aside procurement. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical running through December 2026, which serves as the parent vehicle for...
- <p>The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Ibrance 125 mg tablets (7-count package).</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a global pharmaceutical supply vehicle. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of April 20, 2026.</p>
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply...
- <p>The Defense Logistics Agency issued a $8,561.41 delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for IBRANCE 75 mg capsule 21s, with ultimate completion on April 23, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside.</p>
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Ibrance 125 mg tablets (7-count). Place of performance is Conshohocken, PA. Ultimate completion date is April 20, 2026. The order is firm fixed price with no set-aside and represents a call against the parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which supplies pharmaceutical products and medical...
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for IBRANCE 125 MG capsules (21-unit package), under a firm fixed-price arrangement. Place of performance is Conshohocken, PA. The order is due for completion by April 15, 2026. This is a call against the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for Ibrance 125 mg tablets (7-count packages) with a ceiling value of $8,555.21. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 16, 2026. This delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which provides...
- <p>The Defense Logistics Agency issued a $51,331.26 delivery order to Amerisourcebergen Drug Corp on March 24, 2026, for supply of Ibrance 125 mg tablets under a firm fixed-price contract.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, Pennsylvania. Ultimate completion date is April 14, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for Ibrance 100 mg capsule 21-count units with an ultimate completion date of April 27, 2026. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This vehicle supports pharmaceutical and medical supply deliveries globally to military healthcare programs. Place of performance is...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF6G9Delivery Order
The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for IBRANCE 100 MG TABLET 7S, with ultimate completion by April 22, 2026. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside used.
Generated 7/2/26, 2:31 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 3/31/26 |